CHELSEA WAGNER: Open Payments
NPI 1427769082 · NILES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 22 payments from 14 companies in 2025. Trend: 2023 $393 · 2024 $500 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $55 |
| ABBVIE INC. | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Corium, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: REXULTI, VRAYLAR, TRELEGY ELLIPTA, Qelbree, JARDIANCE, VAXNEUVANCE, Azstarys, Jornay PM.
Industry payments across MI — which companies pay providers there.
